Inventor · disambiguated record
Linda C. Burkly
Also filed as: BURKLY LINDA · BURKLY LINDA C
23 granted patents·34 pending applications·645 citations·filing 1991–2022
97Inventor score
Top patents by PatentIndex Score
57 records- 0195US8784823B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2012·Granted Jul 22, 2014·38 cites·7 claims
- 0295US8293237B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofBURKLY LINDA C·Filed 2008·Granted Oct 23, 2012·40 cites·19 claims
- 0393US7208151B2Tweak receptor agonists as anti-angiogenic agentsBIOGEN IDEC INC·Filed 2001·Granted Apr 24, 2007·36 cites·13 claims
- 0493US5932214ATreatment for inflammatory bowel disease with VLA-4 blockersBIOGEN INC·Filed 1997·Granted Aug 3, 1999·90 cites·15 claims
- 0591US5888507ATreatment for insulin dependent diabetesBIOGEN INC·Filed 1995·Granted Mar 30, 1999·87 cites·14 claims
- 0690US7731963B2TWEAK receptor agonists as anti-angiogenic agentsBIOGEN IDEC INC·Filed 2007·Granted Jun 8, 2010·11 cites·33 claims
- 0789US6770745B2Common gamma chain blocking agentsBIOGEN IDEC INC·Filed 2001·Granted Aug 3, 2004·24 cites·1 claims
- 0888US8728475B2Methods for treating inflammatory bowel diseaseBURKLY LINDA C·Filed 2011·Granted May 20, 2014·14 cites·26 claims
- 0988US7445778B2Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses thereforCURIS INC·Filed 2001·Granted Nov 4, 2008·16 cites·52 claims
- 1088US5871734ATreatment for asthma with VLA-4 blocking agentsBIOGEN INC·Filed 1997·Granted Feb 16, 1999·58 cites·22 claims
- 1187US6616926B1Methods of modulating lipid metabolism and storageCURIS INC·Filed 2000·Granted Sep 9, 2003·21 cites·8 claims
- 1287US6482409B1Treatment for inflammatory bowel disease with a vcam-1/1gG fusion proteinBIOGEN INC·Filed 1998·Granted Nov 19, 2002·48 cites·11 claims
- 1386US6943146B2Method for promoting neovascularizationBIOGEN IDEC INC·Filed 2001·Granted Sep 13, 2005·25 cites·9 claims
- 1483US8506958B2Methods for treating TWEAK-related conditionsBURKLY LINDA C·Filed 2009·Granted Aug 13, 2013·6 cites·9 claims
- 1583US5871732AAnti-CD4 antibody homologs useful in prophylaxis and treatment of AIDS, ARC and HIV infectionBIOGEN INC·Filed 1991·Granted Feb 16, 1999·68 cites·21 claims
- 1681US9775899B2Treating neurological disordersBIOGEN MA INC·Filed 2012·Granted Oct 3, 2017·3 cites·24 claims
- 1781US8048422B2Tweak binding antibodiesBIOGEN IDEC INC·Filed 2007·Granted Nov 1, 2011·7 cites·4 claims
- 1880US2023135399A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 1979US9321840B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2014·Granted Apr 26, 2016·2 cites·15 claims
- 2078US8048635B2Measurement of soluble Tweak levels for evaluation of lupus patientsBIOGEN IDEC INC·Filed 2007·Granted Nov 1, 2011·5 cites·18 claims
- 2177US6323027B1Common gamma chain monoclonal antibody blocking agentsBIOGEN INC·Filed 1998·Granted Nov 27, 2001·39 cites·19 claims
- 2276US9011859B2Methods for treating TWEAK-related conditionsBIOGEN IDEC INC·Filed 2013·Granted Apr 21, 2015·2 cites·22 claims
- 2375US7176184B2Treatment for inflammatory bowel disease with a fibronectin polypeptideBIOGEN IDEC INC·Filed 2002·Granted Feb 13, 2007·5 cites·9 claims
- 2466US2019233530A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB BIOPHARMA SPRL·Filed 2019·Application pending·0 cites
- 2560US2007253902A1Treatment for inflammatory bowel diseaseBIOGEN IDEC MA INC A MASSACHUS·Filed 2006·Application pending·0 cites
- 2658US2008124278A1Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereofTAYLOR FREDERICK R·Filed 2007·Application pending·0 cites
- 2758US2015017155A1Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereofBIOGEN IDEC INC·Filed 2014·Application pending·0 cites
- 2858US2007244053A1Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejectionKIRK ALLAN D·Filed 2006·Application pending·0 cites
- 2958US2016200823A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB PHARMA SA·Filed 2016·Application pending·0 cites
- 3056US2008279853A1Treatment of cancerBIOGEN IDEC INC·Filed 2007·Application pending·0 cites
- 3156US2012183542A1Treating neurological disordersBURKLY LINDA C·Filed 2011·Application pending·0 cites
- 3254US2008187544A1Treating and evaluating inflammatory disordersBURKLY LINDA C·Filed 2007·Application pending·0 cites
- 3353US2012015024A1Methods for treating tweak-related conditionsBURKLY LINDA C·Filed 2011·Application pending·0 cites
- 3453US2006193856A1Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereofTAYLOR FREDERICK R·Filed 2005·Application pending·0 cites
- 3552US2006240004A1Methods for treating tweak-related conditionsBURKLY LINDA·Filed 2003·Application pending·0 cites
- 3652US2007292440A1CD154 blockade therapy for pancreatic islet tissue transplantationKENYON NORMA S·Filed 2006·Application pending·0 cites
- 3751US2015291688A1Methods For Treating Tweak-Related ConditionsBIOGEN IDEC INC·Filed 2015·Application pending·0 cites
- 3851US2014093519A1Methods for pancreatic tissue regenerationBURKLY LINDA·Filed 2013·Application pending·0 cites
- 3951US2011002924A1Tweak receptor agonists as anti-angiogenic agentsBIOGEN IDEC INC·Filed 2010·Application pending·0 cites
- 4051US2005112125A1Methods of modulating lipid metabolism and storageCURIS INC·Filed 2003·Application pending·0 cites
- 4151US2009324602A1Anti-fn14 antibodies and uses thereofBIOGEN IDEC INC·Filed 2009·Application pending·0 cites
- 4251US2006013808A1Treatment for asthmaBIOGEN INC A MASSACHUSETTS COR·Filed 2005·Application pending·0 cites
- 4350US2009124993A1Treating neurological disordersBURKLY LINDA C·Filed 2006·Application pending·0 cites
- 4450US2005208053A1Treatment for insulin dependent diabetesBIOGEN INC A MASSACHUSETTS COR·Filed 2005·Application pending·0 cites
- 4550US2002119150A1Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejectionUS NAVY·Filed 2002·Application pending·0 cites
- 4650US2016243224A1Tweak antagonists for treating lupus nephritis and muscle atrophyBIOGEN MA INC·Filed 2014·Application pending·0 cites
- 4749US2010284933A1Biomarkers of Multiple SclerosisBIOGEN IDEC INC·Filed 2007·Application pending·0 cites
- 4848US9730947B2Method of treating lupus nephritisBURKLY LINDA C·Filed 2011·Granted Aug 15, 2017·0 cites·14 claims
- 4948US2006003932A1Method for promoting neovascularizationJAKUBOWSKI ANIELA·Filed 2005·Application pending·0 cites
- 5048US2003072754A1CD154 blockade therapy for pancreatic islet tissue transplantationBIOGEN INC·Filed 2002·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →